This inventor holds 1 USPTO granted patent. Top assignee: University of Georgia Research Foundation Inc. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Jarvis Hill
Introduction
Jarvis Hill is a notable inventor based in Athens, GA (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of complex compounds. His work focuses on the development of methods that enhance drug discovery processes.
Latest Patents
Jarvis Hill holds a patent for the "Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation." This patent describes a method for the direct synthesis of complex N,N,O-trisubstituted hydroxylamines through N—O bond formation. The method is versatile, utilizing a wide variety of commercially available alcohols and secondary amines. It enables the construction of large fragment-based libraries of trisubstituted hydroxylamines, which are crucial for drug discovery. The disclosed hydroxylamines exhibit low basicity, high stability at ambient temperatures, and a lack of reactivity towards enzymes that can cause mutagenicity in less-substituted hydroxylamines.
Career Highlights
Jarvis Hill is affiliated with the University of Georgia Research Foundation, Inc., where he continues to advance his research. His innovative approach to synthesis has positioned him as a key figure in his field.
Collaborations
Throughout his career, Jarvis has collaborated with esteemed colleagues such as David Crich and Asiri Hettikankanamalage. These collaborations have further enriched his research and contributed to the advancement of chemical synthesis techniques.
Conclusion
Jarvis Hill's work exemplifies the intersection of innovation and practical application in chemistry. His contributions to the synthesis of hydroxylamines are paving the way for advancements in drug discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile